Pharmaceutical and Pharmacological Approaches in Food Processing Technology: Implications for Bioactive Stability, Delivery, and Functional Food Development

The convergence of pharmaceutical sciences and food processing technology has created new opportunities for designing foods that not only provide nutrition but also deliver targeted health benefits. In recent years, consumers have increasingly shifted toward functional foods and nutraceuticals due to rising awareness of chronic disease prevention, immune enhancement, and the therapeutic potential of bioactive compounds (Granato et al., 2020). However, many naturally occurring bioactives-such as polyphenols, vitamins, carotenoids, flavonoids, peptides, probiotics, and omega-3 fatty acids-exhibit poor stability during processing and storage or demonstrate limited absorption and bioavailability in the human body (McClements, 2020). These challenges have driven the integration of pharmaceutical approaches, particularly drug-delivery and formulation strategies, into food systems to protect sensitive compounds and optimize their physiological effectiveness.

 

From a pharmacological perspective, understanding how food-derived bioactives interact with biological systems is essential for predicting efficacy, metabolism, and safety. Pharmacokinetic parameters such as absorption, distribution, metabolism, and excretion (ADME) vary widely among bioactives and are often influenced by the food matrix and processing methods used (Shao & Hathcock, 2008). Thermal processing, pH changes, oxidation, and enzymatic degradation can significantly diminish therapeutic bioactives. Consequently, incorporating delivery systems inspired by pharmaceutical sciences-such as nanoemulsions, liposomes, biopolymer nanoparticles, hydrogels, microcapsules, and controlled-release matrices-has become a promising solution for improving stability and targeted delivery (Zhong & Jin, 2020).

 

Advances in encapsulation technology represent one of the most significant intersections between pharmacy and food processing. Techniques including spray drying, freeze drying, coacervation, extrusion, ultrasonication, and emulsification are widely used to entrap volatile, sensitive, or low-solubility compounds to preserve their functionality (Singh et al., 2022). These techniques protect bioactives from environmental stressors such as heat, oxygen, moisture, and light while enabling controlled release in specific sites within the gastrointestinal tract. Liposomal encapsulation, for instance, has shown strong potential in improving the delivery of antioxidants, omega-3 fatty acids, and plant-based polyphenols (Munin & Edwards-Levy, 2011). Similarly, nanoemulsion systems enhance solubility and absorption of poorly water-soluble compounds like curcumin and resveratrol, thereby improving their pharmacological activity (Yadav et al., 2021). Food processing technology also benefits from pharmaceutical insights into material science, excipient compatibility, and stability modeling. Biodegradable polymers such as alginate, chitosan, pectin, and whey proteins function as effective carriers for bioactive encapsulation, similar to their use in drug-delivery formulations (de Souza Simões et al., 2017). Their capacity to form stable gels, films, and matrices allows for controlled release, improved shelf life, and enhanced sensory quality of fortified foods without compromising safety. Additionally, novel technologies such as cold plasma, high-pressure processing, pulsed electric fields, and ultrasonication can modify structural properties of bioactives or carriers, further improving their functional performance (Pankaj et al., 2018). Pharmacologically, the incorporation of these technologies is crucial for ensuring that bioactive compounds exert their intended therapeutic actions once consumed. For example, the bioavailability of polyphenols and flavonoids is significantly enhanced when delivered through nanoencapsulated systems, resulting in improved antioxidant, anti-inflammatory, and cardioprotective effects (Martins et al., 2022). Similarly, encapsulated probiotics exhibit increased survival through gastric transit and improved colonization of beneficial gut bacteria (Zhang et al., 2021). Regulatory bodies such as the European Food Safety Authority (EFSA) and the U.S. Food and Drug Administration (FDA) emphasize safety evaluation, toxicological assessment, and substantiation of health claims in functional foods. The adoption of pharmaceutical stability studies, controlled dosing approaches, and toxicological risk assessments strengthens the scientific basis for developing safe and effective functional foods (Akhtar et al., 2022).

 

Overall, the integration of pharmaceutical and pharmacological principles into food processing represents a transformative approach to designing next-generation functional foods. It ensures improved stability, targeted delivery, enhanced bioavailability, and scientifically validated health benefits of bioactive compounds. As the global demand for health-promoting foods continues to rise, the synergy between these fields will play a crucial role in shaping the future of food innovation and public health.

 

2. Pharmaceutical Principles Relevant to Food Processing:

2.1 Drug-Delivery Concepts Applied to Food Systems:

Pharmaceutical drug-delivery science focuses on improving the solubility, stability, and controlled release of active compounds-principles that are directly relevant to food bioactives. Many nutraceuticals face limitations similar to drugs, such as poor aqueous solubility (e.g., curcumin, resveratrol), rapid degradation (e.g., vitamin C), or low intestinal permeability (polyphenols). Delivery systems such as nanoemulsions, solid lipid nanoparticles, and liposomes enable these compounds to exhibit enhanced absorption and systemic bioavailability (Yadav et al., 2021). Food technologists now increasingly adopt pharmaceutical formulation strategies to:

●            protect bioactives from oxidation or heat

●            improve solubility and dispersibility

●            enhance uptake through intestinal membranes

●            slow release for prolonged physiological effects

●            mask unwanted taste, odor, or bitterness

For example, nanoemulsified curcumin exhibits significantly improved bioavailability compared to free curcumin due to increased surface area and improved intestinal permeability (McClements, 2020).

 

2.2 ADME Considerations for Food-Derived Bioactives:

Pharmacokinetics-absorption, distribution, metabolism, and excretion (ADME) is crucial for understanding the fate of bioactive compounds in the body. Unlike pharmaceutical drugs, food bioactives often interact with the food matrix, digestive enzymes, gut microbiota, and transport proteins, making their pharmacokinetics more complex.

 

Absorption:

Bioactives such as flavonoids often require hydrolysis or microbial breakdown before intestinal absorption. Encapsulation technologies can improve absorption by protecting compounds during gastric transit.

 

Distribution:

Lipophilic compounds such as carotenoids typically associate with chylomicrons, affecting their distribution to tissues.

Metabolism:

Many plant polyphenols undergo extensive first-pass metabolism, reducing their systemic concentration. Controlled-release systems can improve plasma retention.

 

Excretion:

The rapid elimination of certain compounds (e.g., anthocyanins) reduces therapeutic impact. Sustained-release delivery helps maintain physiological levels for longer durations. Understanding ADME behavior helps food scientists tailor delivery systems to improve uptake and enhance biological effects (Shao & Hathcock, 2008).

2.3 Physicochemical Properties Influencing Bioactive

 

Stability:

Pharmaceutical formulation science places strong emphasis on understanding molecular properties such as:

●            solubility

●            partition coefficient (log P)

●            pKa

●            hygroscopicity

●            melting point

●            oxidation potential

●            photostability

These properties directly determine how a bioactive behaves during food processing and storage.

For example:

●            Vitamin C rapidly oxidizes during thermal processing; encapsulation reduces degradation.

●            Omega-3 fatty acids are highly susceptible to oxidation; microencapsulation improves their shelf life.

●            Polyphenols degrade under alkaline pH; pH-sensitive carriers enhance stability.

Applying these physicochemical principles enables food technologists to design matrices that protect bioactives and deliver them efficiently for maximum physiological benefit.

 

3. Pharmacological Basis of Bioactive Compounds in Foods:

3.1 Mechanisms of Action of Key Nutraceuticals:

Food-derived bioactive compounds exert diverse pharmacological effects that contribute significantly to disease prevention and health enhancement. Phytochemicals such as flavonoids, carotenoids, phenolic acids, alkaloids, and terpenoids display antioxidant, anti-inflammatory, antidiabetic, antihypertensive, antimicrobial, and anticancer activities (Martins et al., 2022). Their mechanisms of action include modulation of enzyme activity, interaction with cellular receptors, scavenging of free radicals, and regulation of gene expression.

 

For example:

●            Polyphenols such as quercetin and catechins inhibit lipid peroxidation and modulate NF-κB and MAPK pathways, reducing oxidative stress and inflammation.

●            Carotenoids like lycopene and β-carotene act as potent singlet-oxygen quenchers and influence immune modulation.

●            Bioactive peptides derived from milk, soy, or fish exhibit ACE-inhibitory properties, contributing to hypertension management.

●            Dietary fibers and prebiotics modulate gut microbiota composition, exerting metabolic and immunological benefits.

●            Probiotics produce bioactive metabolites such as short-chain fatty acids (SCFAs) that regulate inflammation and improve gut barrier integrity.

These pharmacological mechanisms make bioactive-rich foods effective candidates for functional foods and nutraceutical formulations when supported by suitable delivery technologies.

 

3.2 Pharmacokinetics and Bioavailability Challenges:

Despite strong therapeutic potential, most bioactives suffer from low bioavailability, a major barrier to their clinical relevance. Pharmacokinetic challenges arise from:

 

Low Water Solubility:

Compounds such as curcumin and resveratrol have poor solubility, resulting in minimal absorption in the gastrointestinal tract.

 

Unfavorable Partition Coefficients:

Highly lipophilic molecules are not readily absorbed unless incorporated into emulsified or lipid-based delivery systems.

 

Instability During Gastrointestinal Transit:

pH fluctuations, digestive enzymes, and bile salts degrade or metabolize sensitive compounds.

 

First-Pass Metabolism:

Polyphenols undergo rapid hepatic and intestinal metabolism, decreasing systemic availability.

Limited Permeability Across Intestinal Epithelium:

Hydrophilic compounds and high-molecular-weight polyphenols show poor transport across enterocytes.

 

Pharmaceutical approaches are used to address these challenges:

●            Nanoemulsions increase solubility and membrane permeability.

●            Liposomal carriers protect compounds from enzymatic degradation.

●            Biopolymer-based nanoparticles enhance intestinal uptake.

●            Controlled-release matrices optimize absorption windows.

By improving pharmacokinetic profiles, food products can deliver therapeutic levels of bioactives more effectively.

 

3.3 Food Matrix Interactions and Metabolic Implications:

The food matrix plays a critical role in modulating the pharmacological potential of bioactives. Interactions among nutrients, macromolecules, and food structure influence release, absorption, and bioactivity.

 

Protein–Polyphenol Interactions:

Polyphenols often bind to proteins, reducing their free concentration but improving delivery through complex formation. During digestion, these complexes may release the polyphenols gradually, enhancing bioavailability.

 

 

Lipid Matrix Effects:

Lipophilic bioactives show enhanced absorption when delivered in fat-rich matrices. Emulsion-based systems significantly improve the bioaccessibility of carotenoids and fat-soluble vitamins.

 

Fiber and Carbohydrate Interactions:

Dietary fibers can trap bioactives and modulate their release in the colon, influencing microbial metabolism and the production of beneficial metabolites.

 

Gut Microbiota Modulation:

Microbial biotransformation affects the pharmacological activity of several compounds. For example, ellagitannins are converted into urolithins by gut microbes, which have stronger anti-inflammatory and antioxidant properties.

 

Processing-Induced Matrix Modifications:

Processing methods such as homogenization, fermentation, and extrusion can alter matrix properties and influence bioactive mobility, release kinetics, and pharmacological behavior.

Understanding these interactions is crucial for designing functional foods where the food matrix enhances, rather than inhibits, the health-promoting properties of bioactives.

 

4. Impact of Food Processing on Bioactive Stability:

Food processing plays a pivotal role in determining the stability, efficacy, and bioavailability of bioactive compounds. While processing is essential for safety, shelf-life extension, and sensory improvement, it can significantly alter the structural integrity and pharmacological potential of sensitive molecules. Understanding how processing affects these compounds is crucial for applying pharmaceutical strategies that minimize degradation and enhance functionality.

 

4.1 Thermal Processing Effects:

Thermal treatments including pasteurization, sterilization, blanching, baking, drying, and extrusion are widely used in the food industry. However, high temperatures often accelerate degradation reactions such as oxidation, hydrolysis, and isomerization.

 

Heat-Sensitive Vitamins:

●            Vitamin C, thiamine, and folate are highly susceptible to thermal breakdown. Their degradation follows first-order kinetics influenced by temperature and oxygen exposure.

●            Encapsulation in polysaccharides or liposomes extends thermal stability during processing.

Polyphenols and Flavonoids:

Heat may cause polymerization, epimerization, or loss of hydroxyl groups, reducing antioxidant capacity. For example:

●            Catechins in green tea undergo epimerization at high temperatures, reducing bioactivity.

 

Carotenoids:

Carotenoids such as lycopene and β-carotene undergo trans–cis isomerization and oxidation during heating. However, moderate heating can sometimes increase bioaccessibility by softening plant tissues.

 

Proteins and Peptides:

Bioactive peptides can denature or aggregate during heating, reducing their functional properties such as ACE-inhibitory effects.

 

Lipids:

Omega-3 fatty acids oxidize rapidly at high temperatures. Microencapsulation significantly reduces thermal oxidation. Thus, thermal degradation highlights the need for pharmaceutical stabilization strategies to preserve bioactives during processing.

 

4.2 Non-Thermal Processing Technologies:

Non-thermal technologies aim to minimize nutrient loss while ensuring safety and extending shelf life. These technologies are more compatible with pharmacologically sensitive compounds.

 

High-Pressure Processing (HPP):

HPP inactivates microorganisms without high heat. It preserves vitamins, pigments, polyphenols, and enzymes more effectively than thermal processing.

●            Enhances extractability of bound polyphenols.

●            Maintains structure of probiotics when combined with protective carriers.

Cold Plasma:

Cold plasma generates reactive species that inactivate microbes at ambient temperatures (Pankaj et al., 2018).

●            Minimal damage to nutrients and bioactives.

●            Can modify surface properties to enhance functional ingredient binding.

Pulsed Electric Fields (PEF):

PEF breaks cell membranes, enhancing the release and extraction of polyphenols and carotenoids.

●            Suitable for juices, beverages, and liquid foods.

●            Preserves antioxidant capacity better than pasteurization.

 

 

Ultrasonication:

Ultrasound cavitation enhances extraction of bioactives and improves emulsification.

●            Beneficial for nanoemulsion formation.

●            Enhances solubility and dispersibility of hydrophobic molecules.

These methods are ideal for foods containing pharmacologically active ingredients requiring minimal degradation.

4.3 Oxidation, pH, and Enzymatic Degradation:

Bioactives degrade not only due to processing temperature but also due to exposure to oxygen, changes in pH, and enzymatic activity during processing and storage.

Oxidation:

Polyunsaturated fatty acids, polyphenols, carotenoids, and vitamins are prone to oxidative breakdown.

●            Oxygen exposure leads to off-flavors, discoloration, and potency loss.

●            Antioxidant incorporation and encapsulation slow oxidation.

pH Changes:

Acidic or alkaline conditions induce structural changes:

●            Anthocyanins degrade rapidly in alkaline pH.

●            Vitamin C remains more stable in acidic conditions.

●            Encapsulation in pH-sensitive materials enables targeted release and protection.

Enzymatic Degradation:

Enzymes such as polyphenol oxidase (PPO) or peroxidase (POD) can degrade phenolic compounds.

●            Blanching or enzyme inhibitors may be used to prevent enzymatic oxidation.

●            Encapsulation slows enzyme–bioactive interactions.

Understanding these degradation pathways enables the design of protective systems that minimize loss and enhance stability.

 

4.4 Structural Modification of Phytochemicals and Nutrients:

Processing conditions can lead to structural modifications that either decrease or sometimes improve bioactive function.

 

Isomerization:

●            Carotenoids transform from trans to cis forms, affecting antioxidant capacity and bioavailability.

Maillard Reaction Products:

●            Interaction between reducing sugars and amino acids can trap phenolics or degrade peptides.

●            But some Maillard products exhibit antioxidant effects.

Hydrolysis:

●            Processing-induced hydrolysis may increase the availability of bound phenolics.

●            Fermentation generates new bioactive peptides from proteins.

Crystallinity Changes:

●            The amorphous or crystalline state of compounds influences solubility and dissolution rate, similar to pharmaceuticals.

These structural changes determine the final pharmacological effect of bioactive-enriched food products.

 

5. Pharmaceutical Delivery Systems in Food Technology:

Pharmaceutical delivery systems have been increasingly adopted in food processing to enhance the stability, solubility, protection, and bioavailability of bioactive compounds. Many functional ingredients—such as polyphenols, carotenoids, probiotics, peptides, and lipophilic vitamins—are chemically unstable or poorly absorbed. Techniques originally developed in pharmaceutical sciences now provide sophisticated solutions for delivering these compounds effectively in food matrices (Augustin & Hemar, 2009; McClements, 2020).

 

5.1 Microencapsulation Techniques:

Microencapsulation is widely used to entrap sensitive food bioactives within protective microcapsules. It prevents degradation caused by heat, oxygen, light, and interaction with other food components (Goula & Adamopoulos, 2012).

 

5.1.1 Spray Drying:

Spray drying is the most commonly applied microencapsulation method in the food industry due to its low cost, scalability, and ability to transform liquids into stable powders (Jafari et al., 2008).

Key Applications:

●            Encapsulation of flavors and essential oils

●            Stabilization of probiotics

●            Protection of omega-3 fatty acids

●            Preservation of heat-sensitive vitamins and

natural pigments

 

Spray drying effectively improves storage stability and reduces oxidation, although it may be unsuitable for extremely heat-labile compounds (Fang & Bhandari, 2012).

 

5.1.2 Freeze Drying:

Freeze drying (lyophilization) is a gentle dehydration technique used for highly sensitive bioactives. The sublimation process preserves molecular structure, antioxidant capacity, and microbial viability better than thermal methods (Shishir & Chen, 2017).

Applications:

●            Probiotic stabilization

●            Preservation of plant polyphenols and enzymes

●            Encapsulation of vitamins and peptides

Despite its excellent retention properties, freeze drying is energy-intensive and time-consuming (Rattes & Oliveira, 2007).

 

5.1.3 Coacervation:

Coacervation involves phase separation of biopolymers to form coating layers around core materials. It achieves high encapsulation efficiency and controlled release profiles (Gouin, 2004).

Applications:

●            Flavor retention in bakery and beverage products

●            Protection of carotenoids and essential oils

●            Masking bitterness of plant extracts

●            Stabilization of sensitive polyunsaturated fatty acids

 

Complex coacervation using gelatin–gum arabic remains one of the most successful encapsulation strategies in food systems (Schrooyen et al., 2001).

5.2 Nano-Delivery Systems:

Nanotechnology offers advanced delivery solutions for poorly soluble or easily degraded bioactives. Nanocarriers improve absorption, bioavailability, and controlled release due to their small size and large surface area (McClements & Xiao, 2017).

 

5.2.1 Nanoemulsions:

Nanoemulsions are submicron emulsions (<200 nm) with enhanced kinetic stability and improved solubilization of hydrophobic compounds (Qian & McClements, 2011).

Uses:

●            Delivery of curcumin, β-carotene, vitamin D, and omega-3 fatty acids

●            Beverage fortification

●            Natural antioxidant incorporation

Nanoemulsions significantly enhance intestinal absorption of lipophilic nutrients (Yuan et al., 2008).

5.2.2 Nanoparticles:

Biopolymer-based nanoparticles (e.g., chitosan, zein, whey protein) allow controlled or targeted release and improve intestinal uptake (Kumar et al., 2013).

 

Food Applications:

●            Encapsulation of polyphenols

●            Mineral and vitamin delivery

●            Color and flavor stabilization

●            Probiotic protection during digestion

Their mucoadhesive nature enhances bioactive retention in the gastrointestinal tract (Sanna et al., 2015).

 

5.2.3 Solid Lipid Nanoparticles (SLNs):

SLNs use solid lipids to encapsulate lipophilic bioactives, offering strong physical stability and oxidative protection (Mehrad et al., 2018).

Applications:

●            Carotenoid delivery (β-carotene, lycopene)

●            Stabilization of omega-3 oils

●            Encapsulation of vitamins A, D, E, and K

Their controlled-release behavior makes them suitable for functional beverages and dairy products (Bahari & Hamishehkar, 2014).

 

5.3 Liposomal and Vesicular Systems:

Liposomes-phospholipid-based vesicles-are widely used in pharmaceutical drug delivery and increasingly applied in food fortification (Mozafari, 2010).

 

Advantages:

●            High encapsulation efficiency

●            Suitable for both hydrophilic and hydrophobic compounds

●            Enhanced bioavailability and cellular uptake

Food Applications:

●            Omega-3 fortification in milk and yogurt

●            Polyphenol-enriched functional beverages

●            Mineral delivery (iron, zinc, folate)

●            Encapsulation of peptides and enzymes

Their biocompatibility and GRAS status make liposomes attractive for food applications (Ghorbanzade et al., 2017).

 

5.4 Polymer-Based Controlled Release Carriers:

Natural polymers such as alginate, pectin, starch, whey protein, and chitosan are used to create controlled-release delivery systems analogous to oral pharmaceutical formulations (Heidebach et al., 2010).

 

Functional Benefits:

●            pH-responsive release (intestinal targeting)

●            Improved thermal and oxidative stability

●            Prevention of nutrient–matrix interactions

●            Protection of probiotics and enzymes

Applications:

●            Iron fortification without sensory defects

●            Encapsulation of plant extracts

●            Microcapsules in beverages, cereals, and confectionery

●            Sustained release of antioxidants and flavors

Polymer networks greatly improve the stability of bioactives during processing and digestion (Anal & Singh, 2007).

 

5.5 Hydrogels and Biopolymer Networks:

Hydrogels are hydrophilic, three-dimensional polymer networks capable of entrapping substantial water and bioactives. Their structural similarity to biological tissues makes them suitable for controlled release in foods (Ahmed, 2015).

Polymers Used:

●            Alginate

●            Carrageenan

●            Pectin

●            Gelatin

●            Cellulose derivatives

Applications:

●            Probiotic encapsulation in bead-type hydrogels

●            Delivery of peptides, minerals, and antioxidants

●            Flavor release during chewing

●            Active packaging systems with embedded antimicrobials

Hydrogels can be engineered to release bioactives in response to pH, temperature, or ionic strength, similar to smart pharmaceutical systems (Peppas et al., 2016).

 

6. Applications in Functional Food Development:

Pharmaceutical and pharmacological strategies offer advanced tools to improve the functional, nutritional, and therapeutic value of foods. By integrating controlled-release systems, nano-carriers, and stabilization techniques, food technologists can enhance the delivery, absorption, and physiological efficacy of bioactive ingredients in functional foods. These approaches help overcome barriers such as poor stability, low solubility, degradation during processing, and limited bioavailability-challenges commonly encountered with vitamins, probiotics, polyphenols, peptides, and minerals. As a result, modern functional foods increasingly mirror pharmaceutical delivery principles to achieve targeted health benefits (McClements, 2020; Anal & Singh, 2007).

 

6.1 Fortification with Vitamins, Minerals, and Antioxidants:

Fortification aims to replenish or enhance essential micronutrients in food systems, but many vitamins and antioxidants are highly sensitive to environmental stressors such as oxygen, heat, light, and pH. Pharmaceutical-inspired encapsulation and stabilization technologies help protect micronutrients during processing, storage, and digestion.

 

Vitamin fortification: Lipid-based nanoemulsions and microencapsulation significantly improve the stability and bioavailability of fat-soluble vitamins such as A, D, E, and K. Nanoemulsions enhance dispersion in aqueous foods and improve intestinal absorption through increased surface area and interaction with lipid absorption pathways (Salvia‐Trujillo & McClements, 2016).

 

Mineral fortification: Minerals such as iron, zinc, and calcium often cause undesirable sensory changes or interact with food components. Encapsulation using polymers, proteins, and liposomes reduces reactivity and masks metallic flavors (Hurrell, 2003). Iron microencapsulation has been especially important in cereal fortification to prevent lipid oxidation.

 

Antioxidant incorporation: Polyphenols and carotenoids have high therapeutic potential but poor stability. Encapsulation via spray drying, liposomes, or biopolymeric nanoparticles helps prevent oxidative degradation and enhances absorption (Silva et al., 2019). For example, curcumin embedded in nanoemulsions demonstrates significantly improved solubility and bioactivity. Overall, fortified foods benefit from controlled release systems that ensure nutrient availability at the site of absorption, reducing over-fortification and enhancing efficacy (McClements, 2020).

 

6.2 Delivery of Probiotics and Synbiotics:

Probiotics and synbiotics require protection against gastric acidity, bile salts, moisture, and temperature fluctuations. Pharmaceutical delivery systems ensure survivability during processing, storage, and gastrointestinal transit.

 

Microencapsulation of probiotics: Techniques such as spray drying, extrusion, and coacervation with alginate, chitosan, whey protein, or starch enhance microbial viability (Anal & Singh, 2007). Coacervated microcapsules provide excellent acid resistance and controlled release in the intestinal environment.

 

Synbiotic formulations: Combining probiotics with prebiotics (inulin, fructooligosaccharides) enhances microbial stability and promotes targeted colonization. Encapsulation further improves the synergy by protecting both components from premature degradation.

 

Advanced probiotic carriers:

●            Lipid-based carriers stabilize cells and allow controlled release.

●            Hydrogels provide moisture barriers and support viability in harsh environments (Burgain et al., 2011).

●            Nanoencapsulation enhances adhesion to intestinal mucosa and improves colonization efficiency (Riaz Rajoka et al., 2017).

 

These approaches extend the functional life of probiotic products such as yogurts, beverages, supplements, dairy alternatives, and fermented foods.

 

6.3 Incorporation of Plant-Based Bioactives:

Plant-based ingredients—polyphenols, flavonoids, terpenoids, carotenoids, and alkaloids—offer strong antioxidant, anti-inflammatory, antimicrobial, and metabolic regulatory benefits. However, many suffer from poor water solubility, instability, and low bioavailability.

 

Nano- and micro-delivery systems: Nanoemulsions, solid lipid nanoparticles, and polymeric nanoparticles significantly improve the solubility and intestinal permeability of hydrophobic phytochemicals such as curcumin, resveratrol, quercetin, and catechins (Yeo & Shahidi, 2020).

Encapsulation for stability: Spray drying, freeze drying, and liposomal carriers protect plant bioactives from oxidation, thermal degradation, and interaction with food components (da Rosa et al., 2019).

 

Functional food applications:

●            Enriched dairy and plant-based beverages containing encapsulated polyphenols

●            Bakery products fortified with antioxidant microcapsules

●            Meat products containing encapsulated herbal extracts for improved shelf life

 

Targeted delivery: Some plant bioactives show site-specific therapeutic effects such as colonic anti-inflammatory activity or antioxidant activity; thus, controlled-release carriers inspired by pharmaceutical systems promote targeted gastrointestinal release (McClements, 2020).

 

6.4 Protein- and Peptide-Based Functional Ingredients:

Proteins and peptides derived from dairy, plants, and marine sources exhibit bioactivities such as antihypertensive, antioxidant, immunomodulatory, and antidiabetic effects. However, they are prone to enzymatic degradation, unfolding, and interactions with food matrices.

 

Strategies to improve delivery and stability:

●            Encapsulation in biopolymer matrices (gelatin, alginate, chitosan) protects peptides against digestive enzymes (Sanguansri & Augustin, 2006).

●            Lipid-based carriers enable co-delivery with hydrophobic components and control release.

●            Maillard conjugation enhances stability and solubility of functional peptides.

●            Protein-based nanoparticles (casein, whey-derived nanoparticles) stabilize bioactive peptides and improve absorption.

 

Applications include functional beverages enriched with peptide fractions, protein bars containing controlled-release peptides, and dietary supplements engineered for extended physiological activity. Pharmacology-inspired systems are critical for improving peptide absorption, which is otherwise limited by proteolysis and poor membrane permeability (Chan et al., 2016).

 

7. Advances in Stability Enhancement and Targeted Delivery:

Advances in pharmaceutical sciences have strongly influenced food processing and functional food design, especially in the stabilization and targeted delivery of sensitive bioactive compounds. Traditional food matrices often fail to protect bioactives such as probiotics, polyphenols, vitamins, peptides, and essential oils from degradation during processing, storage, or digestion. Modern delivery technologies-adapted from pharmacology-enable precise control over release sites, improved gastrointestinal stability, enhanced mucus adhesion, and responsiveness to biological stimuli. These strategies significantly increase the bioefficacy of functional ingredients and broaden their application in food systems (McClements, 2020; Garti & McClements, 2012).

 

7.1 Gastrointestinal Targeting Strategies:

Targeted gastrointestinal delivery aims to ensure that bioactives are released in specific regions of the digestive tract-including the stomach, small intestine, or colon-depending on their intended physiological function. This is particularly important for probiotics, enzymes, phytochemicals, and peptide-based therapeutics.

 

Enteric coatings, inspired by pharmaceutical tablets, protect bioactives from gastric acidity (pH 1–3) and ensure release at intestinal pH (pH 6–7.5). Biopolymers such as alginate, cellulose acetate phthalate, pectin, and shellac are frequently used due to their natural origin and safety in food applications (Rekha & Vijayalakshmi, 2010).

 

Lipid-based carriers, including liposomes, nanoemulsions, and solid lipid nanoparticles, enable lymphatic uptake in the small intestine and bypass first-pass metabolism, enhancing the systemic absorption of hydrophobic nutrients such as curcumin, carotenoids, and vitamin D (Porter et al., 2007).

 

These systems enhance stability against digestive enzymes, bile salts, and pH variations, supporting improved oral bioavailability of functional food ingredients.

 

7.2 Mucoadhesive and Colon-Specific Delivery:

Mucoadhesive technology aims to prolong the residence time of functional bioactives at specific gastrointestinal sites. Adhesion to the mucosal layer increases the local concentration of bioactives and improves absorption.

Mucoadhesive polymers such as chitosan, pectin, carbopol, and modified starch interact with mucin through hydrogen bonding, electrostatic interactions, and chain entanglement (Smart, 2005). This approach enhances the delivery of:

●            Probiotics to the small intestine

●            Peptides and proteins that require longer absorption time

●            Polyphenols with localized anti-inflammatory action

●            Prebiotics designed to modulate gut microbiota

 

Colon-specific delivery is achieved using polysaccharides like pectin, guar gum, inulin, and resistant starch, which remain intact in the upper GI tract but degrade under colonic microbial enzymatic activity (Davaran et al., 2014). This is especially valuable for:

●            Anti-inflammatory phytochemicals

●            Antioxidants targeting colon health

●            Probiotic and synbiotic delivery

●            Peptides susceptible to upper GI digestion

 

These systems mirror pharmaceutical colon-delivery mechanisms and are now widely explored in functional food formulations.

 

7.3 pH-Sensitive and Enzyme-Responsive Systems:

Stimuli-responsive delivery systems enable controlled release based on specific physiological triggers. These “smart” systems are engineered to respond to temperature, pH, digestive enzymes, and redox conditions.

pH-Sensitive Systems:

pH-responsive hydrogels (e.g., alginate, carrageenan, chitosan) swell or degrade selectively under gastrointestinal pH variations.

●            Acidic pH (stomach): Shrink or remain intact to protect the bioactive

●            Neutral/alkaline pH (intestine): Swell to enable release

This mechanism is widely used for probiotics, peptide drugs, polyphenols, and essential oils (Xu et al., 2018).

 

Enzyme-Responsive Systems:

Systems based on enzymatically degradable biopolymers, such as β-glucans, inulin, pectin, or galactomannans, release their contents only when exposed to specific gastrointestinal enzymes or colonic microbiota (Wang et al., 2019).

 

Applications include:

●            Colon-targeted antioxidants

●            Controlled peptide delivery

●            Protection of prebiotics and synbiotics

●            Release of plant bioactives in microbial-rich environments

Both pH- and enzyme-responsive systems improve bioactive stability against digestion and support precision nutritional strategies.

 

7.4 Smart Delivery Using Novel Biopolymers:

The emergence of novel biopolymers and advanced materials has transformed the design of next-generation functional foods. These systems mimic pharmaceutical smart carriers, offering multi-responsive behavior and improved stability.

 

Novel Biopolymer Categories:

1. Nanocellulose and Cellulose Derivatives: Possess high mechanical strength, thermal stability, and tunable surface chemistry, suitable for encapsulating heat-sensitive vitamins and antioxidants (Lin et al., 2019).

2. Protein-Based Nanostructures: Casein micelles, whey protein nanoparticles, and soy protein isolates offer excellent binding and controlled release of hydrophobic nutraceuticals (Livney, 2010).

3. Polysaccharide-Protein Hybrid Matrices: Hybrid coacervates formed from combinations such as gelatin–gum arabic or whey protein–pectin enhances encapsulation efficiency and prevent oxidation of sensitive bioactives like polyphenols and carotenoids (Weiss et al., 2006).

4. Smart Biopolymer Hydrogels: Hydrogels made from alginate, chitosan, κ-carrageenan, or gellan gum can respond to pH or ions (e.g., Ca²⁺ crosslinking), enabling precision release under controlled gastrointestinal conditions. These novel biopolymer systems allow the construction of functional foods with improved stability, targeted release, and enhanced health benefits.

 

8. Safety, Toxicology, and Regulatory Perspectives:

The integration of pharmaceutical-inspired delivery systems into food processing raises important questions concerning safety, toxicology, and regulatory compliance. As functional foods incorporate increasingly complex materials-such as nanocarriers, biopolymers, and microencapsulated bioactives-regulatory bodies such as EFSA, FDA, and FSSAI have strengthened evaluation criteria. Ensuring consumer protection requires rigorous assessment of the materials used, their degradation products, bio-distribution, and potential long-term accumulation. Scientific substantiation is essential not only for approval but also for supporting health claims made on functional food products (Chaudhry et al., 2008; Bouwmeester et al., 2011).

 

8.1 Safety Assessment of Encapsulated Bioactives:

Encapsulated ingredients must undergo safety evaluation to ensure that the delivery system and the encapsulated compound do not pose risks under intended usage. Encapsulation materials-such as polysaccharides, proteins, lipids, and novel biopolymers-are typically considered GRAS (Generally Recognized As Safe). However, when engineered into micro- or nano-sized structures, their physical behavior and bioactivity may change (Augustin & Sanguansri, 2012).

Key safety considerations include:

●            Biodegradability: Materials such as alginate, gelatin, chitosan, or starch must degrade into non-toxic metabolites.

●            Interaction with food matrices: Some encapsulating agents may alter nutrient absorption or interact with other food components.

●            Digestive fate: Release profiles must be compatible with human digestion to avoid accumulation in the GI tract.

●            Stability and shelf-life: Degradation products should not generate harmful compounds during storage or processing (McClements & Xiao, 2017).

Food-grade encapsulation systems typically undergo acute toxicity, genotoxicity, and allergenicity tests, similar to pharmaceutical excipients, before being approved for use.

 

8.2 Toxicological Evaluation of Nanomaterials:

Nanotechnology-based delivery systems-such as nanoemulsions, solid lipid nanoparticles, nanofibers, and polymeric nanoparticles-have unique physicochemical properties that require specialized toxicological assessment. Nanomaterials may exhibit enhanced reactivity, altered cellular uptake, or unexpected interactions with biological barriers (Donaldson & Poland, 2013). Toxicological evaluation focuses on:

●            Particle size and morphology: Smaller particles may cross epithelial barriers more readily.

●            Surface charge and functionalization: These influence cellular uptake and immune responses.

●            Bioaccumulation: Persistent nanoparticles may accumulate in tissues, requiring long-term toxicity studies.

●            Oxidative stress potential: Some nanoparticles can generate reactive oxygen species (Fröhlich, 2012).

●            GI tract interaction: Digestion may transform nanoparticle structures, creating new entities requiring assessment.

Regulatory bodies encourage case-by-case assessment, given the diversity of nano-enabled food systems and the evolving understanding of nano–bio interactions.

 

8.3 EFSA, FDA, and FSSAI Guidelines:

EFSA (European Food Safety Authority):

EFSA requires comprehensive safety dossiers for novel foods, food additives, and nano-enabled materials. Key evaluations include:

●            Full characterization of the delivery system

●            In vitro and in vivo toxicity data

●            Migration and degradation studies

●            Dietary exposure assessment

EFSA emphasizes transparency and mandates nanoscale-specific data for any engineered nanomaterial used in food (EFSA, 2021).

FDA (U.S. Food and Drug Administration):

The FDA classifies food-grade encapsulation and delivery materials under:

●            GRAS substances,

●            Food Additives Amendment,

●            New Dietary Ingredient (NDI) notifications, and

●            Nano-specific guidance documents.

FDA requires manufacturers to demonstrate that structural modifications—such as reducing particle size to nanoscale-do not alter safety or functionality (FDA, 2014).

FSSAI (Food Safety and Standards Authority of India):

FSSAI follows Codex Alimentarius principles and mandates:

●            Safety assessment of novel ingredients

●            Approval of processing aids and encapsulating agents

●            Nano-specific guidance under “Food Safety and Standards (Approval of Non-Specified Food and Food Ingredients)”

India’s regulatory framework for nanotechnology is evolving, with emphasis on risk assessment, labelling, and post-market surveillance (FSSAI, 2022).

 

8.4 Health Claim Substantiation

Health claims must be supported by strong scientific evidence demonstrating efficacy at the recommended consumption levels. Functional food developers must meet the requirements set by regulatory bodies: Types of Claims include;

1.           Nutrient function claims – e.g., “Vitamin D contributes to immune function.”

2.           Structure/function claims – e.g., “Probiotics support digestive health.”

3.           Disease risk reduction claims – e.g., “Plant sterols reduce blood cholesterol.”

Evidence Requirements Regulatory agencies require:

●            Randomized controlled trials (RCTs) demonstrating significant health benefits

●            Mechanistic studies showing mode of action

●            Bioavailability studies proving that encapsulated bioactives are absorbed and active

●            Dose–response data confirming effective intake levels (Rao et al., 2016)

 

Encapsulation and delivery systems must not only protect the bioactive but also demonstrate improved or equivalent bioactivity compared to traditional formulations. Health claims are approved only when the ingredient’s efficacy is scientifically validated and consumer use is safe.

 

9. Current Trends and Future Perspectives:

9.1 Personalized Nutrition and Pharmacological Profiling:

The integration of personalized nutrition with pharmacological profiling is reshaping functional food development. Advances in nutrigenomics, metabolomics, and microbiome mapping enable the design of bioactive-loaded foods tailored to individual metabolic responses (Ordovas et al., 2018). Such personalization improves efficacy by aligning nutrient delivery with unique genetic and physiological characteristics. Drug-delivery principles—such as controlled release, targeted absorption, and bioavailability optimization—are now being adapted to customize nutrient timing and dosage in foods (Zhang & Zhao, 2020). Smart encapsulation carriers capable of responding to individual gastrointestinal conditions and microbiota composition represent a promising innovation for next-generation personalized functional foods (de Roos & Brennan, 2021).

 

9.2 AI and Computational Modeling in Delivery System Design:

Artificial intelligence (AI), machine learning (ML), and computational simulations are rapidly transforming the design of food-grade delivery systems. Predictive modeling enables accurate forecasting of encapsulation efficiency, release kinetics, and degradation behavior under different processing and storage conditions (Sun et al., 2022). AI-driven optimization tools help identify the best combinations of polymers, emulsifiers, and processing parameters for micro- and nanoencapsulation (Kumar et al., 2023). Molecular dynamics simulations also provide mechanistic insights into interactions between bioactives and encapsulating agents, allowing rational design of stable and efficient delivery vehicles (Wang & Chen, 2021). These technologies significantly accelerate research while reducing experimental costs and formulation errors.

 

9.3 Sustainable Encapsulation Materials:

Sustainability is emerging as a key priority in food processing and encapsulation technologies. Biodegradable, renewable, and plant-derived biopolymers—such as alginate, pectin, chitosan, and starch derivatives—are increasingly preferred over synthetic carriers (Charles et al., 2020). Green extraction techniques, solvent-free encapsulation, and eco-friendly nanomaterial synthesis methods are gaining traction to reduce environmental impact (Chemat et al., 2019). Agricultural waste streams, including fruit peels and cereal husks, are being explored as novel encapsulating materials due to their natural fiber, polyphenol, and polysaccharide content (Singh et al., 2022). Sustainable approaches not only enhance consumer acceptance but also support circular bioeconomy goals in the food industry.

 

9.4 Challenges and Opportunities in Industry Adoption:

Despite significant scientific progress, several challenges hinder large-scale industry adoption of pharmaceutical-inspired delivery systems. Regulatory complexities, cost of advanced materials, equipment requirements, and scalability issues remain primary barriers (Bhushan, 2020). Additionally, consumer perception of nanotechnology and encapsulated ingredients can limit market acceptance. However, opportunities are expanding with increasing demand for fortified and functional foods, clean-label products, and precision nutrition (Granato et al., 2020). Continued interdisciplinary collaboration among food scientists, pharmacists, material engineers, and regulatory bodies will be essential for translating cutting-edge delivery technologies into commercially viable products. Future developments are expected to focus on scalable encapsulation processes, hybrid polymer–lipid carriers, and systems with validated health benefits supported by clinical evidence.

The integration of pharmaceutical and pharmacological principles into food processing technology represents a transformative shift toward the development of next-generation functional foods. Advances in microencapsulation, nano-delivery systems, liposomal carriers, and biopolymer-based matrices have significantly improved the stability, targeted delivery, and bioavailability of diverse bioactive compounds, ranging from vitamins and antioxidants to probiotics and therapeutic plant metabolites (Augustin & Sanguansri, 2015; McClements, 2020). These innovations address key challenges associated with degradation during processing, environmental instability, and poor gastrointestinal absorption—issues traditionally faced by both food scientists and pharmaceutical technologists.

 

Emerging delivery approaches such as enzyme-responsive systems, mucoadhesive polymers, and pH-sensitive nanoformulations further contribute to precision targeting within the gastrointestinal tract, enhancing therapeutic potential and consumer health benefits (Gommes et al., 2021; Zhao et al., 2022). The merging of pharmacokinetics, material science, and food engineering has enabled the creation of functional foods that not only provide nutrition but also support disease prevention, metabolic regulation, cognitive health, and immune modulation.

 

Despite significant progress, challenges remain regarding large-scale production, cost-effective formulation, regulatory compliance, and long-term safety-especially for nano-enabled delivery systems (Chaudhry et al., 2017; Duncan, 2011). Regulatory agencies such as EFSA, FDA, and FSSAI continue to refine their frameworks to ensure consumer safety and transparency in health claims, which will be crucial as more bioactive-enriched foods enter the market. Looking ahead, personalized nutrition, AI-driven predictive design, and sustainable biomaterials are expected to play central roles in shaping future food-pharma innovations (Brunton et al., 2020; Salvia-Trujillo & McClements, 2021). As interdisciplinary collaboration strengthens between pharmaceutical scientists, food technologists, and regulatory authorities, the field is poised to deliver highly effective, targeted, and consumer-friendly functional foods that align with modern health and wellness demands.

 

Acknowledgements:

The authors sincerely acknowledge the support and guidance of their respective institutions and laboratories during the preparation of this review.

 

Funding:

This work was not supported by any Funding Agency, which provided financial assistance for literature procurement, data compilation, and manuscript preparation. Additional support from Department of Food Technology, JCT College of Engineering and Technology for access to research facilities and analytical resources is gratefully acknowledged.

 

Conflicts of Interest:

The authors declare that there are no conflicts of interest associated with this publication. All opinions, analyses, and conclusions presented in this review are solely those of the authors and do not necessarily reflect the views of the funding agencies or affiliated institutions.

1.Ahmed, E.M. (2015). Hydrogel: Preparation, characterization, and applications: A review. Journal of Advanced Research, 6(2), 105–121.

2.Akhtar, S., Khalid, N., Ahmed, I., Shahzad, A., & Suleria, H.A.R. (2022). Functional foods and health claims: Regulatory frameworks, scientific validation, and future perspectives. Food Research International, 157, 111213.

3.Anal, A.K., & Singh, H. (2007). Recent advances in microencapsulation of probiotics for industrial applications and targeted delivery. Trends in Food Science & Technology, 18(5), 240–251.

4.Augustin, M.A., & Hemar, Y. (2009). Nano- and micro-structured assemblies for encapsulation of food ingredients. Chemical Society Reviews, 38(4), 902–912.

5.Augustin, M.A., & Sanguansri, L. (2012). Challenges and solutions to incorporation of nutraceuticals in foods. Annual Review of Food Science and Technology, 3, 463–493.

6.Augustin, M.A., & Sanguansri, L. (2015). Nanostructured materials in the food industry. Advances in Food and Nutrition Research, 75, 1–52.

7.Bahari, S., & Hamishehkar, H. (2014). The impact of processing parameters on properties of solid lipid nanoparticles for food applications. Journal of Food Science and Technology, 51(10), 2317–2325.

7.Bouwmeester, H., Dekkers, S., Noordam, M.Y., et al. (2011). Review of health safety aspects of nanotechnologies in food production. Regulatory Toxicology and Pharmacology, 53(1), 52–62.

8.Brunton, N.P., Brennan, C., Monahan, F.J., Scannell, A.G., & Gormley, R. (2020). Future trends in food processing. Food Research International, 137, 109751.

9.Burgain, J., Gaiani, C., Linder, M., & Scher, J. (2011). Encapsulation of probiotics: From laboratory to industrial scale. Journal of Food Engineering, 104(4), 467–483.

10.Chan, L.J., et al. (2016). Advances in peptide delivery for improved bioavailability. Journal of Controlled Release, 240, 202–216.

11.Chaudhry, Q., Scotter, M., Blackburn, J., et al. (2008). Applications of nanotechnologies for the food sector. Food Additives & Contaminants, 25(3), 241–258.

12.Chaudhry, Q., Castle, L., & Watkins, R. (2017). Nanotechnologies in food: Safety and regulatory implications. Food Additives & Contaminants: Part A, 34(4), 504–513.

13.da Rosa, C.G., et al. (2019). Encapsulation of phenolic compounds for food applications. Food Research International, 117, 130–140.

14.Davaran, S., Moradi, A., & Entezami, A.A. (2014). Stimuli-responsive polysaccharide hydrogels for colon-specific drug delivery. Carbohydrate Polymers, 103, 22–31.

15.de Souza Simões, L., Madalena, D., Silva, A.M., & Costa, P. (2017). Biopolymer-based nanoencapsulation systems for food bioactives. Food Hydrocolloids, 68, 19–34.

16.Donaldson, K., & Poland, C.A. (2013). Nanotoxicology: New insights. Particle and Fibre Toxicology, 10(1), 1–12.

17.Duncan, T.V. (2011). Nanotechnology in food packaging and safety. Journal of Colloid and Interface Science, 363(1), 1–24.

18.EFSA. (2021). Guidance on risk assessment of nanomaterials in the food chain. EFSA Journal, 19(8), 6768.

19.Fang, Z., & Bhandari, B. (2012). Polyphenol encapsulation: Review. Trends in Food Science & Technology, 20(10), 570–580.

20.FDA. (2014). Guidance for Industry: Nanotechnology in Manufacturing. U.S. FDA.

21.Fröhlich, E. (2012). Role of surface charge in nanoparticle uptake and toxicity. International Journal of Nanomedicine, 7, 5577–5591.

22.FSSAI. (2022). Regulations for nanotechnology applications. Food Safety and Standards Authority of India.

23.Garti, N., & McClements, D.J. (2012). Encapsulation technologies for active food ingredients. Academic Press.

24.Ghorbanzade, T., Jafari, S.M., Akhavan, S., & Hadavi, R. (2017). Nano-liposomes for fish oil fortification. Food Chemistry, 216, 146–152.

25.Gommes, J., Rios, R., David, S., & Pawlik, A. (2021). Smart delivery systems for gastrointestinal targeting. Trends in Food Science & Technology, 113, 311–325.

26.Goula, A.M., & Adamopoulos, K.G. (2012). New spray drying technique for orange juice. Innovative Food Science & Emerging Technologies, 13, 75–83.

27.Gouin, S. (2004). Microencapsulation: Industrial appraisal. Trends in Food Science & Technology, 15, 330–347.

28.Granato, D., Barba, F.J., Kovačević, D.B., Lorenzo, J.M., Cruz, A.G., & Putnik, P. (2020). Functional food product development. Comprehensive Reviews in Food Science and Food Safety, 19(5), 2265–2291.

29.Heidebach, T., Först, P., & Kulozik, U. (2010). Microencapsulation of probiotics. Critical Reviews in Food Science and Nutrition, 52(4), 291–311.

30.Hurrell, R. (2003). Vegetable proteins and mineral bioavailability. American Journal of Clinical Nutrition, 78, 633S–639S.

31.Jafari, S.M., Assadpoor, E., He, Y., & Bhandari, B. (2008). Encapsulation efficiency during spray drying. Drying Technology, 26, 816–835.

32.Kumar, S., Markandeya, & Nandi, D. (2013). Nanotechnology in nutraceuticals. Journal of Pharmacy and Bioallied Sciences, 5, 21–27.

33.Lin, N., Dufresne, A., & Huang, J. (2019). Nanocellulose composites. Carbohydrate Polymers, 205, 377–396.

34.Livney, Y.D. (2010). Milk proteins as vehicles for bioactives. Current Opinion in Colloid & Interface Science, 15, 73–83.

35.Martins, N., Ferreira, I.C.F.R., & Barros, L. (2022). Polyphenols: Stability and delivery challenges. Trends in Food Science & Technology, 119, 616–628.

36.McClements, D.J. (2020a). Enhancing nutraceutical bioavailability through matrix design. Food Chemistry, 339, 128128.

37.McClements, D.J. (2020b). Encapsulation, protection, and delivery of proteins and peptides. Advances in Colloid and Interface Science, 282, 102211.

38.McClements, D.J. (2020c). Advances in oral delivery of bioactive components. Current Opinion in Food Science, 33, 21–29.

39.McClements, D.J., & Xiao, H. (2017). Encapsulation to enhance nutraceutical bioactivity. Food & Function, 8, 704–719.

40.Mehrad, B., Ravanfar, R., Licker, J., Regenstein, J.M., & Abbaspourrad, A. (2018). Stability of natural colors using solid lipid nanoparticles. Trends in Food Science & Technology, 79, 34–47.

41.Mozafari, M.R. (2010). Nanoliposome preparation and analysis. In Liposomes: Methods and Protocols, 29–50.

42.Munin, A., & Edwards-Levy, F. (2011). Encapsulation of polyphenolic compounds. Pharmaceutics, 3(4), 793–829.

43.Pankaj, S.K., Bueno-Ferrer, C., Misra, N.N., O’Donnell, C.P., Bourke, P., & Cullen, P.J. (2018). Cold plasma in food processing. Trends in Food Science & Technology, 77, 21–31.

44.Peppas, N.A., Huang, Y., Torres-Lugo, M., Ward, J.H., & Zhang, J. (2016). Hydrogels in medicine. Annual Review of Biomedical Engineering, 2, 9–29.

45.Porter, C.J., Trevaskis, N.L., & Charman, W.N. (2007). Lipid-based formulations for oral bioavailability. Advanced Drug Delivery Reviews, 60, 673–691.

46.Qian, C., & McClements, D.J. (2011). Nanoemulsion formation by high-pressure homogenization. Food Hydrocolloids, 25, 1000–1008.

47.Rao, A.V., Rao, L.G., & Agarwal, S. (2016). Nutraceuticals and health claims. Nutrition Research Reviews, 29(2), 247–256.

48.Rattes, A.L.R., & Oliveira, W.P. (2007). Spray drying blackberry pulp. Journal of Food Engineering, 80, 423–436.

49.Rekha, C.R., & Vijayalakshmi, G. (2010). Processing influence on probiotic viability. Journal of Food Science and Technology, 47, 221–226.

50.Riaz Rajoka, M.S., et al. (2017). Nanotechnology strategies for probiotic survival. Food Bioscience, 20, 1–15.

51.Salvia-Trujillo, L., & McClements, D.J. (2016). Enhancing vitamin bioaccessibility via nanoemulsions. Food Chemistry, 192, 696–702.

52.Salvia-Trujillo, L., & McClements, D.J. (2021). Lipid-based delivery systems. Current Opinion in Food Science, 40, 144–151.

53.Sanna, V., Siddiqui, I.A., Sechi, M., & Mukhtar, H. (2015). Resveratrol nanoparticles for cancer treatment. Molecular Pharmaceutics, 12(1), 119–127.

54.Schrooyen, P.M.M., van der Meer, R., & De Kruif, C.G. (2001). Microencapsulation applications in nutrition. Proceedings of the Nutrition Society, 60, 475–479.

55.Shao, A., & Hathcock, J. (2008). Risk assessment of amino acids. Regulatory Toxicology and Pharmacology, 50, 37–49.

56.Shishir, M.R.I., & Chen, W. (2017). Critical review of spray drying fruit/vegetable juices. Trends in Food Science & Technology, 65, 49–67.

57.Silva, C.O., (2019). Antioxidant encapsulation. Food Hydrocolloids, 87, 77–87.

58.Singh, T., Shukla, S., & Mishra, V. (2022). Microencapsulation of bioactives: Techniques and applications. Food Chemistry, 368, 130870.

58.Smart, J.D. (2005). Mucoadhesion mechanisms. Advanced Drug Delivery Reviews, 57, 1556–1568.

59.Wang, W., Rao, C., & Sun, C. (2019). Enzyme-responsive carriers for phenolics. Food Hydrocolloids, 97, 105223.

60.Weiss, J., Takhistov, P., & McClements, D.J. (2006). Functional materials in food nanotechnology. Journal of Food Science, 71(9), R107–R116.

61.Xu, Y., Kim, C., & Hanna, M. (2018). pH-responsive hydrogel systems. Food Hydrocolloids, 76, 61–70.

62.Yadav, H.K.S., Almokdad, Z., Shalaby, M.N., & Deb, P.K. (2021). Nanoemulsions for improved oral delivery. Journal of Drug Delivery Science and Technology, 63, 102540.

63.Yeo, P.L., & Shahidi, F. (2020). Nano-delivery systems for plant bioactives. Trends in Food Science & Technology, 99, 464–476.

64.Yuan, Y., Gao, Y., Zhao, J., & Mao, L. (2008). β-carotene nanoemulsions. Food Research International, 41, 61–68.

65.Zhang, L., Li, D., & Li, J. (2021). Probiotic encapsulation technologies. Food Hydrocolloids, 117, 106732.

66.Zhao, Y., Yuan, C., & Chen, J. (2022). pH- and enzyme-sensitive delivery systems. Food Hydrocolloids, 128, 107612.

67.Zhong, Y., & Jin, Y. (2020). Liposomal nutraceutical delivery. Critical Reviews in Food Science and Nutrition, 60, 2198–2214.